What You Should Know:
– CaryHealth, a digital health company launches its direct-to-patient (DTP) platform, designed to create a seamless, unified patient journey.
– By connecting clinical support, pharmacy fulfillment, and real-time data tracking, CaryHealth delivers a seamless, end-to-end experience that supports patient adherence and gives manufacturers confidence in therapy delivery.
Unifying a Fragmented Patient Journey
The DTP model is rapidly gaining traction, but its success hinges on overcoming fragmentation. Many DTP experiences are currently fragmented due to the use of multiple digital engagement vendors. CaryHealth solves this by combining AI-driven engagement with the supply chain strength of its nationally licensed pharmacy.
“While the shift toward the direct-to-patient model is inevitable, its success hinges on reimagining the patient journey, not just traditional distribution,” said Areo Nazari, CEO and co-founder of CaryHealth. “CaryHealth delivers a customizable and unified digital experience where every touchpoint is connected, personalized, and powered by modern UI/UX frameworks.”.
AI and Data Fabric: Driving Adherence and Efficiency
The platform is engineered to support patients through personalized engagement via CaryHealth’s clinical sequencing engine, making them more likely to adhere to treatment.
For pharmaceutical manufacturers, the system provides powerful, real-time insights:
- CaryConnect Dashboard: Manufacturers gain actionable insights through this dashboard, which incorporates dynamic reporting and A/B testing for patient outreach optimization and overall program performance.
- Agentic Automation: By leveraging its enterprise-grade data fabric and agentic automation layer, CaryHealth helps manufacturers minimize time-to-first-fill and enhance adherence through continuous experience optimization. These capabilities are beyond the architecture of traditional pharmacies.
